M Silicon Biosystems retweeted
Have you registered for #ISLB2022 yet? Less than 48 hours remain to save up to $50!
Secure your spot today and join the #liquidbiopsy experts from around the world. Sign up now and save at: islb.info/ee3e.
@ChristianRolfo @drgandara @UmbertoMalapel1
@MCristofanill
M Silicon Biosystems retweeted
We are pleased to announce the strategic collaboration with MENARINI SILICON BIOSYSTEMS Inc. for the distribution of the CHORUS TRIO system in North America.
Read the full announcement: diesse4covid19.it/_files/upl…
#diesse #chorustrio #diagnostic #solutions #immunesystem
M Silicon Biosystems retweeted
Only two days left to join a Full-Day Webinar on “Liquid Biopsy in the Clinical Setting”, on Saturday, January 15, 2022! (lnkd.in/dBHb5yPi). Registration is free. #liquidbiopsy, #CTCs, #ctDNA, cfDNA, #cellfreeDNA, #personalizedmedicine, #ACTCmeeting, #ACTClab
M Silicon Biosystems retweeted
📣FREE Registration to the
MENARINI Symposium:
🩸CTC phenotyping: an opportunity for identifying treatment relevant biomarkers?
🗓️22/10/21
🕐13:00 Spain
islbcongress.org/symposium-m…
@ChristianRolfo
@UmbertoMalapel1
M Silicon Biosystems retweeted
Winship breast oncologist and clinical investigator Kevin Kalinsky, MD, MS (@kalinskykevin) and @SiliconBio's Cecilia Simonelli, MD, are leading, "Trends in Metastatic Breast Cancer," a webinar for medical professionals on June 15. #bcsm ➡️ fal.cn/3fZ3a
M Silicon Biosystems retweeted
Did you miss the LIVE event?! No worries, you can still register and view the recording! @MCristofanill @SiliconBio @GenomeWeb #LiquidBiopsy #CTCs #PrecisionMedicine #TranslationalResearch
event.on24.com/wcc/r/3033883…
M Silicon Biosystems retweeted
Just published on @BCRJournal our work on the prognostic role of CTCs in patients treated with palbociclib in the TREnd trial + molecular analysis of pure CTCs sorted with @deparray. Read more at rdcu.be/chqTL
M Silicon Biosystems retweeted
Winship's Kevin Kalinsky, MD, MS (@kalinskykevin) and @SiliconBio's Carolyn Hall, PhD, are leading a webinar, "Trends in Metastatic Breast Cancer" on March 16. Dr. Kalinsky will discuss "Updates in Metastatic Triple Negative #BreastCancer." #bcsm ➡️ fal.cn/3dMBb
M Silicon Biosystems retweeted
#WorldCancerDay updates from across the globe:
German researchers found that a liquid biopsy that captures the number of circulating tumor cells in patient blood can be used to predict early treatment response in #breastcancer: ow.ly/oxiO50DqqYB #medtwitter via @uni_ulm
M Silicon Biosystems retweeted
Randomized phase III trial shows that a circulating tumor cells-based decision is non-inferior to a clinician-based decision for choosing between single-agent #endocrinetherapy and #chemotherapy in HR-positive, HER2-negative metastatic #breastcancer ja.ma/3c1axrA
M Silicon Biosystems retweeted
Favorable outcomes after treatment with the HER2-directed lapatinib were indicated by early declines in circulating tumor cell counts in patients w/ metastatic breast cancer who HER2- primary tumors but HER2+ CTCs. @SABCSSanAntonio #SABCS20 #bcsm onclive.com/view/ctc-count-p…
M Silicon Biosystems retweeted
More from #SABCS20: Circulating Tumor Cells May Predict Treatment Response in Metastatic Breast Cancer ow.ly/JPIt50CJH2a #cancerresearch #medtwitter via @uni_ulm
M Silicon Biosystems retweeted
Developing a Novel Assay for Circulating Multiple #Myeloma Cells Using the CELLSEARCH Platform
Register now to understand the power of enumerating circulating MM cells as a potential marker for #disease progression. @SiliconBio
buff.ly/3p9dxGl
M Silicon Biosystems retweeted
Developing a Novel Assay for Circulating Multiple Myeloma Cells Using the CELLSEARCH Platform
Why would circulating Multiple Myeloma Cells (CMMCs) be a potential biomarker for disease progression in Multiple #Myeloma?
buff.ly/3p9dxGl
#Biomarker #Oncology @SiliconBio
M Silicon Biosystems retweeted
🔜ONLY 3 DAYS TO GO!!!
ISLB ANNUAL CONGRESS 2020 #liquidbiopsy
►Don't miss amazing LIVE 🔴▶️Satellite Symposiums!
FREE Registration: islbcongress2020.org
M Silicon Biosystems retweeted
Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America: ow.ly/rGDP50AwJcS $OPGN @SiliconBio
M Silicon Biosystems retweeted
Next Tuesday❕ Join ICBR's Cytometry core and Menarini @SiliconBio for a lunch and learn and DEPArray demo.
Details and registration here: biotech.ufl.edu/event/deparr…
M Silicon Biosystems retweeted
Powered by BlueBee - Discover @SiliconBio's MSBiosuite: A solution to automate processing of raw sequencing data generated with #Ampli1 and #DEPArray #NGS kits #bioinformatics #singlecell siliconbiosystems.com/press-…


























